In their study, four severely obese patients diagnosed with pathogenic heterozygous MC4R variants (2 adults and 2 adolescents) achieved a mean weight reduction of 5.9 kg following 16 weeks of liraglutide treatment, corresponding to a 5.8% reduction from their baseline body weight
Therefore, this study aimed to investigate the effects of LC supplementation on inflammatory mediators, oxidative status, and monitoring parameters in septic ICU-admitted patients
This group includes women who are pregnant or breastfeeding and anyone diagnosed with seizure disorders
Create outcome reporting dashboards: Develop visual representations of clinic-wide outcomes to track progress and identify improvement opportunities
SGLT-2 inhibitors, such as empagliflozin, canagliflozin and dapagliflozin, are considered to have intermediate efficacy for glycemic control, and are associated with weight loss and a low risk of hypoglycemia [6]
Front Endocrinol (Lausanne) 2017;8:6.ArticlePubMedPMC 70